Klotho Neurosciences (KLTO) Competitors $1.23 -0.04 (-3.15%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock KLTO vs. IMMP, TRDA, ESPR, DSGN, NBTX, PRQR, TVRD, TKNO, FENC, and ACIUShould you be buying Klotho Neurosciences stock or one of its competitors? The main competitors of Klotho Neurosciences include Prima BioMed (IMMP), Entrada Therapeutics (TRDA), Esperion Therapeutics (ESPR), Design Therapeutics (DSGN), Nanobiotix (NBTX), ProQR Therapeutics (PRQR), Tvardi Therapeutics (TVRD), Alpha Teknova (TKNO), Adherex Technologies (FENC), and AC Immune (ACIU). These companies are all part of the "pharmaceutical products" industry. Klotho Neurosciences vs. Its Competitors Prima BioMed Entrada Therapeutics Esperion Therapeutics Design Therapeutics Nanobiotix ProQR Therapeutics Tvardi Therapeutics Alpha Teknova Adherex Technologies AC Immune Prima BioMed (NASDAQ:IMMP) and Klotho Neurosciences (NASDAQ:KLTO) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends. Which has more risk & volatility, IMMP or KLTO? Prima BioMed has a beta of 1.71, suggesting that its stock price is 71% more volatile than the S&P 500. Comparatively, Klotho Neurosciences has a beta of 11.08, suggesting that its stock price is 1,008% more volatile than the S&P 500. Does the media prefer IMMP or KLTO? In the previous week, Klotho Neurosciences had 4 more articles in the media than Prima BioMed. MarketBeat recorded 5 mentions for Klotho Neurosciences and 1 mentions for Prima BioMed. Prima BioMed's average media sentiment score of 1.87 beat Klotho Neurosciences' score of 0.63 indicating that Prima BioMed is being referred to more favorably in the media. Company Overall Sentiment Prima BioMed Very Positive Klotho Neurosciences Positive Do analysts rate IMMP or KLTO? Prima BioMed currently has a consensus price target of $7.00, indicating a potential upside of 306.98%. Given Prima BioMed's stronger consensus rating and higher possible upside, equities analysts plainly believe Prima BioMed is more favorable than Klotho Neurosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Prima BioMed 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Klotho Neurosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders believe in IMMP or KLTO? 2.3% of Prima BioMed shares are held by institutional investors. Comparatively, 20.1% of Klotho Neurosciences shares are held by institutional investors. 3.1% of Prima BioMed shares are held by insiders. Comparatively, 26.7% of Klotho Neurosciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, IMMP or KLTO? Klotho Neurosciences has lower revenue, but higher earnings than Prima BioMed. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPrima BioMed$5.14M48.87-$28.01MN/AN/AKlotho NeurosciencesN/AN/A-$6.15M-$0.36-3.42 Is IMMP or KLTO more profitable? Prima BioMed's return on equity of 0.00% beat Klotho Neurosciences' return on equity.Company Net Margins Return on Equity Return on Assets Prima BioMedN/A N/A N/A Klotho Neurosciences N/A -1,779.01%-275.01% SummaryPrima BioMed beats Klotho Neurosciences on 7 of the 12 factors compared between the two stocks. Get Klotho Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KLTO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KLTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KLTO vs. The Competition Export to ExcelMetricKlotho NeurosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$58.49M$2.50B$5.70B$9.51BDividend YieldN/A1.75%4.69%4.01%P/E Ratio-3.429.0528.0720.05Price / SalesN/A757.64448.5799.42Price / CashN/A165.2136.2258.56Price / Book30.755.168.665.87Net Income-$6.15M$30.99M$3.25B$258.55M7 Day Performance-4.65%7.74%4.20%2.23%1 Month Performance-1.60%16.18%10.82%12.76%1 Year PerformanceN/A-1.03%34.70%19.36% Klotho Neurosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KLTOKlotho NeurosciencesN/A$1.23-3.1%N/AN/A$58.49MN/A-3.42N/AIMMPPrima BioMed1.4938 of 5 stars$1.70-0.6%$7.00+311.8%-19.0%$248.27MN/A0.002,021News CoveragePositive NewsUpcoming EarningsTRDAEntrada Therapeutics3.5255 of 5 stars$6.38+3.9%$25.67+302.3%-60.5%$242.12M$210.78M7.88110ESPREsperion Therapeutics3.8097 of 5 stars$1.22+6.1%$7.00+473.8%-36.3%$241.80M$259.57M-1.52200DSGNDesign Therapeutics0.5584 of 5 stars$4.25+4.9%$4.00-5.9%-15.5%$241.27MN/A-4.2940Positive NewsNBTXNanobiotix1.6198 of 5 stars$5.09-0.4%$8.00+57.2%+22.0%$239.89M$39.18M0.00100News CoverageGap UpPRQRProQR Therapeutics2.8831 of 5 stars$2.28-2.6%$8.00+250.9%+20.2%$239.88M$20.46M-6.51180TVRDTvardi TherapeuticsN/A$25.37-2.0%$64.25+153.3%N/A$237.46M$7.14M0.0080TKNOAlpha Teknova2.2219 of 5 stars$4.42+7.5%$10.00+126.2%+58.1%$236.21M$37.74M-9.21240News CoverageAnalyst UpgradeFENCAdherex Technologies2.5177 of 5 stars$8.52+1.3%$13.00+52.6%+32.7%$235.15M$30.91M-16.7110Gap UpACIUAC Immune2.0697 of 5 stars$2.31+11.1%$12.00+419.5%-31.2%$231.95M$28.30M-3.98140Positive News Related Companies and Tools Related Companies Prima BioMed Competitors Entrada Therapeutics Competitors Esperion Therapeutics Competitors Design Therapeutics Competitors Nanobiotix Competitors ProQR Therapeutics Competitors Tvardi Therapeutics Competitors Alpha Teknova Competitors Adherex Technologies Competitors AC Immune Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KLTO) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Klotho Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Klotho Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KLTO Stock Alerts